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P ro te o g ly c a n s  metabolically labelled with [88S]sulphate and basement-membrane HSPG) 
[3H ]glucosam ine or [8H]leucine were isolated from the incubation
—  ^ 4 * 4 4 ft 4
bodies known to react with
m e d iu m  and cell layer of human adult mesangial cells and perlecan) strongly
g lo m e ru la r  visceral epithelial cells sequential DEÀE
c h ro m a to g ra p h y  purification steps followed by gel-filtration 
c h ro m a to g ra p h y . The proteoglycan composition of each peak
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suggesting that the HS side chain and
w a s  analysed by treatment with HNOa, chondroitinase ABC or different from glomerular-basement-membrane HSPG. Toquan-
c h o n d ro it in a se  AC followed by chromatography on Sephadex tify HS we performed an inhibition ELISA using mouse anti-
0 - 5 0  columns. Heparan sulphate proteoglycan (HSPG) and bodies specific for glomerular-basement-membrane HS glyeos-
d e r m a ta n  sulphate proteoglycan were detected in both the culture aminoglycan side chains. Glomerular visceral epithelial
m e d iu m  and cell layer of mesangial cells. Culture medium of produced significantly higher levels of HS (between 197.56
g lo m e ru la r  visceral epithelial cells contained HSPG and a second 
p ro te o g ly c a n  with the properties of a hybrid molecule containing
g/72 h 
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H S P G  and CSPG. Detailed analysis of the hybrid molecule heximide, revealing that it was synthesized ck novo. Expression of
r e v e a le d  th a t it had an apparent molecular mass of 400 kDa. perlecan mRNA, demonstrated using reverse transcriptase PCR,
S X > S /P A G E  of hybrid molecules, after treatment with We
h e p a r i t in a s e  and chondroitinase ABC, revealed a core protein of visceral epithelial cells and mesangial cells have characteristic
8 0  k D a .  Using 1.8% polyacrylamide/0.6 % agarose-gel electro- patterns of proteoglycan production. Glomerular visceral epi-
p h o r e s i s ,  we deduced that the HS and CS were independently thelial cells produced a hybrid proteoglycan containing CS and
a t t a c h e d  to one core protein. Because glomerular-basement- HS independently attached to its core protein,
m e m b r a n e  HSPG is thought to be derived from mesangial cells does not bind to monoclonal and polyclonal antibodies known
a n d  glom erular visceral epithelial cells and this molecule is to react with perlecan. This is the first quantification
in v o lv e d  in several kidney diseases, we investigated its synthesis synthesized by both glomerular
i n  m o r e  detail. Anti-(rat glomerular-basement-membrane HSPG) mesangial cells. Differences in mRN A levels between
m o n o c lo n a l  antibodies (JM403) and anti-(human glomerular- were
INTRODUCTION glomerulus are thought to play an important role in the patho­
genesis of a variety of glomerular diseases associated with changes
T h e  re n a l  glomerulus contains two extracellular matrices, the in GBM charge, proteinuria |^] and matrix accumulation. Several
g lo m e r u la r  basement membrane (GBM) the mesangial that the ILS glycosamtnoglycan e
urinary space < in ,v < . *
m a t r i x  [1], which are produced by the glomerular visceral contribute greatly to the negative charge observed on the G 
e p i t h e l i a l  cells, the glomerular endothelial cells and the mesangial [10 12]. Kanwar et al. [2] showed leakage of ‘“^ -albumin into the 
c e l l s .  O n e  important class of constituents of these matrices are 
t h e  proteoglycans, of which chondroitin/dermatan sulphate 
p r o te o g ly c a n  CSPG/DSPG [2,3] and heparan sulphate proteo-
antm ase treatment ol
t n  sulphate membrane. We found that antibodies against GBM HS induce
phate proteo- an acute selective proteinuria in rats [9], This negative charge
g l y c a n  (H SPG ) [2,4,5] are the major molecules. The quantities results from sulphate and carboxy groups distributed along the
a n d  p ro p o r t io n s  of these constituents may vary between matrices glycosaminoglycan side chains. There have been some reports
p r o d u c e d  by different cell types [6,7]. Proteoglycan molecules that question the contribution o f HS to
c o n s i s t ,  in general, of a core protein and glycosaminoglycan side selectivity [13 15]. Podocalyxin [16] and carboxy groups [17]
c h a i n s  covalently attached to serine or asparagine residues on the could also play a significant role in this respect. However, a
c o r e  p ro te in  [8]. Alterations in the HSPG content of the decreased GBM HS content was found to be accompanied by
A b b r e v i a t i o n s  u s e d : HS, h e p a ra n  s u lp h a te ;  CS, c h o n d r o it in  s u lp h a te ;  DS, d e rm a ta n  s u lp h a te ; H SPG , h e p a ra n  s u lp h a te  p ro te o g ly c a n .  C S P G . 
c h o n d r o i t i n  s u lp h a te  p r o te o g ly c a n ;  D S P G , d e rm a ta n  s u lp h a te  p r o te o g ly c a n ; G B M , g lo m e ru la r  b a s e m e n t m e m b r a n e ;  D M E M . D u lb e c e o 's  m o d if ie d  
E a g i e  s  m e d iu m ;  <5FCS, h e a t- in a c t iv a te d  fe ta l c a lf  s e ru m ; F ITC , f lu o re s c e in  is o th io c y a n a te ; m A b. m o n o c lo n a l a n t ib o d y ;  R T -P C R . re ve rse  t ra n s c r ip ta s e  
P  «t 9 ly c e ra ld e h y d e -3 -p h o s p h a te  d e h y d ro g e n a s e .
1  T o  w h o m  c o r re s p o n d e n c e  s h o u ld  b e  a d d re s s e d .
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increased permeability of the glomerular capillary walls, es­
pecially for anionic molecules such as albumin. It is thought that 
a change in negatively charged molecules in the GBM results in 
the albuminuria seen in many types of glomerulopathy including 
membranous glomerulonephritis [18], congenital nephrotic syn­
drome [19], systemic lupus erythematosus [20], minimal lesions 
and diabetic nephropathy [21-25]. Klein et al. studied the 
production of HS and CS/DS in both human fetal glomerular 
visceral epithelial cells [7] and human fetal mesangial cells 
[26,27] in vitro, by metabolic labelling with N a286SO,j and 
[3H]glucosamine. Thomas et al. [28] published results of similar 
experiments using human adult mesangial cells, and these 
investigators observed differences between proteoglycans 
synthesized by fetal and adult cells. These differences mainly 
consisted of higher proportions of CSPG and HSPG produced 
by adult mesangial cells as compared with fetal mesangial cells. 
Also HSPGs synthesized by adult and fetal mesangial cells were 
not the same.
Therefore the first part of this paper is a detailed analysis of 
proteoglycan production by mesangial cells and glomerular 
visceral epithelial cells isolated from adult human kidneys. The 
two cell populations were investigated under the same conditions 
in order to exclude any experimental differences. These studies 
were performed using metabolic labelling of the cells with 
Na235S 0 4 and [8H]glucosamine or [3H]leucine followed by 
extensive purification steps.
The second part focuses on HSPG, because of the importance 
of this molecule in several kidney diseases. To our knowledge, no 
studies have shown quantitative differences in HS synthesis by 
glomerular visceral epithelial cells and mesangial cells. The 
earlier reports of HS quantification used metabolic labelling 
only. However, although this method is sensitive, it can give 
serious errors in proteoglycan levels if it is the sole method used. 
Recently, antibodies have been developed that specifically 
recognize the HS glycosaminoglycan side chains of GBM HSPG, 
and these antibodies can be used in a sensitive inhibition ELISA 
[25] to measure HS. Therefore, HS synthesis in both visceral 
epithelial cells and mesangial cells can be quantified in vitro, and 
peak fractions obtained by HPLC can be identified. Recent 
studies have demonstrated that these monoclonal antibodies 
have high reactivity against the large basement-membrane 
HSPG, perlecan. Our knowledge of the complete nucleotide 
sequence of perlecan [29] gives us the opportunity to investigate 
its expression in different tissues and cell types. Expression of 
perlecan mRNA by glomerular visceral epithelial cells and 
mesangial cells was investigated using reverse transcriptase PCR
(RT-PCR).
80 //m sieve. This suspension of more than 90 % decapsulated 
glomeruli was resuspended in DMEM containing 100 units/ml 
penicillin, 100 /¿g/ml streptomycin and 20% 5FCS. Immediately 
after the first cellular outgrowth from the glomeruli, glomerular 
visceral epithelial cells appeared and were detached with PBS/ 
EDTA (20 mM). These cells were subsequently grown in T75 
flasks in DMEM containing 5% &FCS [31]. Outgrowing 
mesangial cells (generally appearing within 21 days of seeding) 
were selectively subcultured in 24-well plates as described [30]. 
The pure populations of cells were washed, treated with trypsin 
(0.05%) and cultured in T25 and T75 flasks (Greiner, 
Frickenhausen, Germany). Cells were used between the second 
and eighth passage. For labelling studies, cells were grown in 
either T75 flasks or 24-well plates. Culture media for ELISA 
were collected from cells grown in 12-well tissue culture plates 
(Costar, Cambridge, MA, U.S.A.).
MATERIALS AND METHODS
Immunofluorescence studies
Both cell types were characterized morphologically by phase- 
contrast microscopy, and immunofluorescence was performed 
with different specific antibodies. Cells were grown on sterile 
glass coverslips in DMEM containing 10 % &FCS. The cells were 
fixed in acetone for 5 min at 0 °C, air-dried and incubated with 
primary antibody for 30 min. After extensive washing with PBS, 
the cells were incubated with appropriate fluorescein isothio- 
cyanate (FITC)-conjugated anti-IgG or IgM for 30 min in the 
dark. After three washes with PBS, the slides were mounted in 
l,4-diazobicyclo[2.2.2]octane/glycerol, assessed for fluorescence 
at 340-380 nm and photographed through a Leitz microscope 
(Wetzlar, Germany).
The following antisera were used : FITC-phalloidin for actin 
(Sigma); mouse anti-cytokeratin monoclonal antibody (mAb) 
(RGE 53) and anti-desmin mAb (Eurodiagnostics, Apeldoorn, 
The Netherlands); rabbit anti-(human factor VIII) (von 
Willebrand factor) (Dakopatts); mouse anti-CD 10 mAb (anti- 
CALLA) (Dakopatts); rabbit anti-(human CR1); anti-5D9 
(TN9) specifically recognizing proximal tubular epithelial cells 
and TN10 specifically recognizing glomerular visceral epithelial 
cells [32] were a gift from Dr. G. Müller and Dr. M. Nesper 
(Medizinische Klinik, Tübingen, Germany); rabbit anti-(human 
collagen types I, III and IV) (Southern Biotechnology Associates, 
Birmingham, AL, U.S.A.); mouse anti-(human collagen type IV 
a l and type IV a3) mAbs [33] were a gift from Dr. J. Wieslander 
(Statens Serum Institute, Copenhagen, Denmark); rabbit anti- 
(human fibronectin) (Sigma) and anti-laminin mAbs (Cal- 
biochem, La Jolla, CA, U.S.A.); goat anti-(human HSPG) 
[25,34] and mouse anti-HS mAbs were produced as described 
previously [9,251.
Cell culture
Mesangial cells and glomerular visceral epithelial cells were 
cultured using glomeruli obtained from human kidneys (donors 
aged between 1.5 and 66 years) which could not be used for 
transplantation because of anatomical abnormalities. Mech­
anical dissociation and sequential sieving were performed as 
described [30,31]. In brief, renal cortices were minced and passed 
sequentially through sieves of mesh 400 /¿m, 200 //,m and 150 fim. 
The sieved material was then exposed to collagenase type-I A 
(Sigma Chemical Co., St. Louis, MO, U.S.A.) for 20 min at 
37 °C. Collagenase was inactivated by the addition of cold
medium (DMEM) (Seromed;Dulbecco’s modified 
Biochrom K.G., Berlin, Germany) containing 5 0//O heat-
inactivated fetal calf serum (£FCS) (Hyclone Laboratories, 
Logan, UT, U.S.A.). The sieved material was collected on a
Metabolic labelling
Confluent human mesangial cells and glomerular visceral epi­
thelial cells were labelled in leucine- and sulphate-free DMEM 
supplemented with 2%  5FCS. Metabolic labelling of cells in 
media supplemented with a dose response of £FCS revealed that 
a 2%  concentration induced a maximal incorporation of the 
label (results not shown). De novo synthesis of proteoglycans was 
studied by dual labelling with Na2:,5S 0 4 (lOO/zCi/ml; carrier- 
free; NEN, Boston, MA, U.S.A.) and [3H]glucosamine 
(25 /¿Ci/ml) or [3H]leucine (50 /¿Ci/ml) (Amersham Inter­
national, Amersham, Bucks., U.K.). After 24 h at 37 °C, the 
radioactive media were removed and the cells were washed three 
times with cold PBS. The incubation media and three washes 
were pooled and extensively dialysed against 0.5 M sodium 
acetate, pH 5.8, at 4 °C with the following protease-inhibitor
cocktail: 10 mM EDTA, 5 mM phenylmethanesulphonyl 
fluoride, 2 mM benzamidine, 50 mM /?-aminohexanoic acid, 0.5 
unit/ml aprotinin and 5 mM iodoacetamide. The cells and 
extracellular matrix were scraped from the plastic dishes with a 
rubber ‘policeman’ and extracted for 24h at 4°C by gently 
shaking in 4 M guanidinium chloride containing 50 mM sodium 
acetate, pH 5.8, and the protease-inhibitor cocktail, after dialysis 
as above. Both cell-media and cell-layer fractions were finally 
dialysed against DEAE buffer (6 M urea, 50 mM Tris, 0.2 % 
CHAPS and protease-inhibitor cocktail, pH 7.0). The first puri­
fication step involved a DEAE anion-exchange (5 ml). The 
fractions eluted in the salt gradient of 0.1-1.0 M NaCl in DEAE 
buffer were pooled, dialysed and loaded on to a DEAE 
anion-exchange Bio-Gel TSK DEAE-5PW HPLC column 
(75 mm x 7.5 mm; Bio-Rad, Richmond, CA, U.S.A.). After ap­
plication of the sample, the column was extensively washed with 
DEAE buffer, and bound material was eluted in a linear NaCl 
gradient (0.1-1.0M). A flow rate of 1 ml/min was used and 
1.0 ml fractions were collected. 35S and 3H radioactivity were 
measured by adding aliquots of the fractions to fluorophore 
Ultima Gold (Packard) and counting in a Beckman LS-7500 
scintillation counter. The conductivity of each fraction was 
measured using a CDM3 Radiometer conductivity meter 
(Copenhagen, Denmark) and expressed in milliSiemens (mS). 
Peak fractions were pooled, dialysed against distilled water at
4 °C, lyophilized and stored at — 20 °C until use.
Degradation of proteoglycans
The 3r,S-/3H-labelled glycosaminoglycans were released from the 
proteoglycan protein core using 0.05 M NaOH in the presence of 
1 M NaBH4 for 1 h at 73 °C [35]. The reaction was stopped by 
dropwise addition of acetic acid to pH 7 followed by Sephadex 
G-50 column chromatography (bed size 0.9 cm x 25 cm), equi­
librated with 0.5 M sodium acetate, pH 7.0, containing 0.2% 
CHAPS, 10 mg/ml BSA and 1 mg/ml heparin. The contents of 
the column void volume were used for the following analyses: 
glycosaminoglycan composition and reactivity in ELISAs for HS 
glycosaminoglycan and HSPG core protein.
Glycosaminoglycan composition
Glycosaminoglycans were analysed by treatment with low-pH 
(pH 1) HNOa [19,36,37] or chondroitinase ABC (2.5 munits) or 
AC (2.5 munits) (both from Sigma). 35S-/3H-labelled chains that 
were 10% less sensitive to chondroitinase AC than to chondro­
itinase ABC were designated DS, whereas those equally sensitive 
to both enzymes were referred to as CS. After treatment, the 
reaction mixtures were analysed using a Sephadex G-50 column 
(0.9 cm x 25 cm) as described above. Some proteoglycans were 
analysed in more detail using a Hiload 16/60 Superdex HR200 
HPLC column (Pharmacia, Uppsala, Sweden) equilibrated with
0.5 M sodium acetate buffer, pH 7.0, containing 0.2 % CHAPS. 
The column was calibrated with thyroglobulin (669 kDa), apo- 
ferritin (443 kDa), ^-amylase (200 kDa), alcohol dehydrogenase 
(150 kDa), albumin (66 kDa) and carbonic anhydrase (29 kDa).
Electrophoresis in composite gels of 1.8% polyacrylamide/
0.6% agarose was performed by the method of Carney et al. 
[38] with minor modifications. The gel was stained with 0.2% 
Toluidine Blue in 0.1 M acetic acid to visualize HSPG from 
bovine kidney, dried and exposed to X-ray film (Kodak) at 
-  70 °C. The intensity of the bands on the autoradiogram was 
determined with a 2202 Ultrascan laser densitometer (LKB,
Woerden, The Netherlands).
To determine the apparent molecular mass of some of the
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proteoglycan cores, SDS/PAGE was used. The different proteo­
glycans were purified as described above and subjected to either 
chondroitinase ABC and/or heparitinase under the same con­
ditions. The samples were boiled for 10 min and subjected to 
SDS/PAGE (5 % gels) under reducing conditions.
ELISA of HS
HS was detected by an inhibition ELISA using mouse antibodies 
specific for HS glycosaminoglycan side chains as previously 
described by van den Born et al. [25]. In brief, a constant amount 
of mAb JM403 was diluted to a concentration giving 80 % of the 
maximal ELISA signal and preincubated with an equal volume 
(60 jul) of HS (from bovine kidney; Seikagaku, Tokyo, Japan) at 
concentrations ranging from 0.2 to 100 /tg/ml for 1 h at 37 °C, 
followed by 1 h at 4 °C, and tested in the ELISA with HS as the 
coated antigen. ELISAs were performed over a linear range on 
the culture media of glomerular visceral epithelial cells and 
mesangial cells. For these studies cells were grown in 12-well 
tissue culture plates to confluence and incubated for 24 h in 
maintenance culture medium (DMEM containing 0.5 % £FCS). 
They were then cultured for 3 days in DMEM containing
0.5% (5FCS; the used media were collected and cells counted 
using a Coulter counter (Coulter Electronics, Mijdrecht, The 
Netherlands). To study whether HS was synthesized de novo, 
replicate wells of cells were grown in 12-well tissue culture plates. 
The cells were washed three times with PBS and maintained for
24 h in DMEM containing 0.5 % &FCS. Subsequently they were 
cultured in either maintenance medium alone or medium con­
taining 1 /¿g/ml cycloheximide. At timed intervals culture media 
were removed and HS was measured using the above ELISA. 
Cells were counted as above. Simultaneously, cells were grown 
with or without cycloheximide, washed and then cultured for 
additional periods in normal media, and HS in the media was 
determined.
Semiquantitative measurement of perlecan mRNA
Total RNA was isolated from glomerular visceral epithelial ce 
and mesangial cells grown in T25 flasks in medium as describes 
by Chomczynski and Sacchi [39]. For PCR, oligonucleotide 
primers specific for human perlecan [40] corresponded to 
nucleotide positions 1234-1253 (P1,5' -TT AC AT GC AGCCA A- 
ACTCGTC-3'; nested cDNA primer), 362-380 (P2, 5'-TTTC- 
GAGAGGTGTCCGAGGCT-3'; sense PCR primer) and 
613-631 (P3, 5'-TTATCTTGGGAACTGGGGCAC-3'; anti­
sense PCR primer) and glyceraldehyde-3-phosphate dehydro­
genase (GAPDH)-specific [41] oligonucleotides corresponded to 
nucleotide positions 340-359 (Gl, 5'-GAGATGATGACCTTT- 
TGGC-3'; nested cDNA primer), 4-22 (G2, 5'-GTGAAGGT- 
CGGAGTGTCAACG-3'; sense PCR primer) and 286-303 
(G3, 5'-GGTGAAGACGCAGTGGACTC-3'; antisense PCR 
primer). RT-PCR was performed with the help of the geneAmp 
thermostable RT-PCR kit (Perkin-Elmer Cetus). Reverse trans­
cription of 1 jug of total RNA was performed at 70 °C for
15 min using a mixture of 10 ng each of primers P1 and G 1 and
5 units of reverse transcriptase in 20 ¡A. Amplifications of divided 
cDNA samples representing approx. 0.4 /¿g of total RNA were 
carried out separately for 30 (GAPDH) or 35 (perlecan) cycles. 
The PCR mixture contained 100 ng of PCR primers (P2-P3; 
G2-G3) and all four dNTPs (200 ¡M  each) in 100 ¡A of reverse 
transcriptase buffer containing 2.5 mM MgCl2. Temperature 
cycles were set as follows: 94 °C for 1 min, 50 °C for 1 min, 2 min 
for 72 °C. PCR products were resolved by agarose-gel electro­
phoresis.
762 N. F. van Det and others
Statistical analysis
Data for control and experimental groups are expressed as 
means ±  S.D. Statistical analysis was performed using Student’s 
t test for unpaired samples, and a P value of ^  0.05 was used to 
determine significance.
Table 1 Marker antibodies used to define cultured glomerular visceral 
epithelial cells and mesangial cells and their staining by immunofluorescence
Antibody
Glomerular
visceral
epithelial
cells Mesangial cells
RESULTS 
Characterization of human mesangial cells and glomerular 
visceral epithelial cells
Mesangial cells formed elongated cells in multilayers, whereas 
glomerular visceral epithelial cells formed a confluent monolayer 
of polygonal cells (Figures la  and lb  respectively). The cells were 
incubated with specific antisera (Table 1) and examined by 
immunofluorescence microscopy. Distinctly different staining 
patterns were observed for the two types of cell. Glomerular 
visceral epithelial cells reacted positively with CD 10 (anti- 
CALLA) [31] and mAbs specific for them, TNI 0 [32], but did not 
react with mAbs directed against the C3b receptor (CR1), 
proximal tubular epithelial cells (TN9) [32] or von Willebrand 
factor. Mesangial cells reacted negatively with CD10, cytokeratin 
and von Willebrand factor, but showed a uniform fluorescence of 
the actin filaments with FITC-phalloidin. Both types of cell gave 
positive extracellular-matrix staining for collagen type IV a l ,  
fibronectin, laminin, HS and HSPG core protein when cells were 
cultured for 3 days (Table 1). Culturing mesangial cells for 3 days 
resulted primarily in cytoplasmic staining of HS in a filamentous 
pattern (Figure lc). This staining could be abolished by addition 
of HS. Staining of HS on glomerular visceral epithelial cells 
cultured for 3 days was typically in the extracellular matrix 
(Figure Id). Goat anti-mouse-FITC was used as a negative
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control (Figure le). Staining of HSPG core protein gave similar 
patterns to those observed for HS. All mesangial cells but no 
glomerular visceral epithelial cells stained positively for collagen
I and III (Table 1).
Incorporation of radioactively labelled sulphate and glucosamine 
into macromolecules
Glomerular visceral epithelial cells and mesangial cells were 
metabolically labelled for 24 h with Na235S 04 and [3H]glucos- 
amine in sulphate-free medium supplemented with 2 % 
£FCS. After 24 .h, the culture media were harvested. They 
contained 53.2-70.0% of the total incorporated radioactivity. 
The guanidinium chloride fraction containing both the intra­
cellular components and extracellular matrix represented 
30.0-46.7% of the total incorporated radioactivity. Less than 
1 % was left on the culture dishes after extraction. Both the cell 
supernatant and cell layer were purified twice by DEAE anion- 
exchange chromatography. The second purification step involved 
an HPLC column. For both cell types this resulted in the 
separation of two more or less distinct peaks (I and II) which 
were pooled as indicated in Figure 2. A portion of the total 
labelled macromolecules retained on the HPLC column were 
eluted at the beginning of the salt gradient (fractions 1-40). 
Glycosaminoglycans were not detected in these fractions.
Degradation of proteoglycans
The culture medium of mesangial cells contained almost equal 
amounts of HSPGs (peak 150.8 +  2.8 % of the total proteoglycan 
production; n — 3) and DSPGs (peak II 49.2±2.8%  of total; 
n =  3) (Table 2 A). The cell layer of mesangial cells also contained
Figure 1 Phase-contrast microscopy of glomerular cells in culture (a,b) HS (peak I 58.2+4.7%  of total proteoglycan production; 
and immunofluorescence microscopy of glomerular cells in culture stained n — 3) and DS (peak II 41.8±5.7% of the total; n — 3). 
with mAb JM403 (c,d) Glomerular visceral epithelial cells synthesized different proteo-
(•,c) Mesangial cells: (M) glomerular visceral epithelial cells; (e) negative control (goat anti- S*ycans t h a , n  di?  mes^ngja! cetls The majority of the proteo-
mouse-FITCor rabbitanti-goat-FITC). Magnification for (a) and (b) x  100; magnification for glycan produced consisted of HSPG (peak I 61.5±5.1 ^  of the 
(c), (d) and (e) x 400. total). Peak II (38.5 ±5 .1%  of total) contained proteoglycans
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Figure 2 HPLC of 38S-/3H-labelled macromolecules synthesized by human mesanglal cells (a,b) and glomerular visceral epithelial cells (c,d) in culture
Cells were labelled as described in the Materials and methods section. The culture medium and cell layer were harvested and extracted. The 35S/3H-labelled macromolecules were lirst purified 
on a 5 ml DEAE anion-exchange column in DEAE buffer, pH 7.0. The second purification step involved an HPLC DEAE column. Profiles of the incorporated 35S-labelled macromolecules from the 
culture medium (a,c) and the cell layer (b,d) are shown. Elution was with a linear NaCI gradient.
Table 2 Composition of proteoglycans produced by mesangial cells (A) 
and glomerular visceral epithelial cells (B) In culture
Numbers are percentage sensitivity; ELISA data are given as positive (inhibition >  30%) or 
negative (Inhibition <  30%).
Culture medium Cell layer
„  , i  | ,  -» rr .  p ..»  , i l A A '  .  >J— - * , f .  a ,* *  h W  P I * lY,
II
A
Chondroitinase ABC 
Chondroitinase AC
h no2
Anti-HS
Anti-(HSPG core protein) 
B
Chondroitinase ABC 
Chondroitinase AC
h no2
Anti-HS
Anti-(HSPG core portion)
0% 
0% 
>  95% 
Positive 
Positive
>  95% 
0% 
0% 
Negative 
Negative
0% 
0% 
>  95% 
Positive 
Positive
>  95% 
0% 
0% 
Negative 
Negative
0% 
0% 
>  95% 
Positive 
Positive
35.4%
34.3%
50.1%
Negative
Negative
0%
0%
> 9 5 %
Positive
Positive
>  95%
>  95%
0%
Negative
Negative
sensitive to both chondroitinases and H N 0 2 (Table 2B): 35.4% 
was sensitive to chondroitinase ABC, 34.3 % to chondroitinase 
AC, and 50.1 %  to HNO, (Table 2B and Figure 3), revealing
either the presence of a mixture of CSPG and HSPG or a hybrid 
molecule with the different glycosaminoglycan side chains at­
tached to one core protein. However, no positivity was observed 
in either the HS ELISA or the ELISA using polyclonal antibodies 
directed against the HSPG core protein, indicating that HS in 
this peak is different from that in peak I of the culture medium 
of these cells and is possibly not perlecan, as these antibodies 
have been shown to recognize this basement-membrane HSPG. 
The cell layer of these cells contained HS (79.4 ±0.2%  of total;
= 3). All calculations 
were based on [3H]glucosamine radioactivity.
n 3) and CS (20.6±0.2% of total; n
Analysis of the CS- and HS-bearing proteoglycans
To investigate whether the contents of peak II of the culture 
medium of glomerular visceral epithelial cells contains a mixture 
of, or a hybrid molecule derived from, HSPG and CSPG, we 
metabolically labelled these cells with 50 /iCi/ml [®H]leucine and 
100 /iCi/ml Na2a8S 0 4 for 24 h in sulphate- and leucine-free 
DMEM containing 2 % iFCS. The different proteoglycans were 
isolated as described in the Materials and methods section. Peak
II (Figure 2c) was loaded on to a Superdex HR200 size-exclusion 
column equilibrated in 0.5 M sodium acetate buffer, pH 7,0, 
containing 0.2 % CHAPS. A similar method was used to analyse 
a mixture of peak I and II from mesangial cells (Figure 2a), the 
latter serving as controls. Figure 4 shows the profiles. Peak II 
isolated from the culture medium of glomerular visceral epithelial
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Figure 3 Sephadex G-50 gel-filtration chromatography of peak II of glomerular-visceral-epithelial-cell culture medium after purification by HPLC
Peak I! was treated with NaBH„, subjected to Sephadex G-50 gel filtration (a), and the contents of the void volume subsequently analysed for reactivity with HN02 (b), chondroltlnase ABC (c) 
or chondroltlnase AC (d).
cells consists of one main peak and one small shoulder after 
Superdex HR200 separation (Figure 4a), whereas a mixture of 
peaks I and II isolated from mesangial-cell culture medium 
eluted as two peaks (Figure 4d). When the control mixture (peaks 
I and II of mesangial-cell culture medium) was treated with 
chondroitinase ABC (which cleaves both DS and CS chains), a 
small unsulphated [*H]leucine peak appeared at 0.142 (Figure 
4e), which represents the CSPG core protein without the attached 
CS side chains. Treatment of the control mixture of mesangial- 
cell culture medium with H N 0 2 resulted in another small 
unsulphated [3H]leucine peak with a K av of 0.127 (Figure 4f), 
representing the HSPG core protein. However, treatment of 
peak II from glomerular-visceral-epithelial-cell culture medium 
(HS/CS) with either H N 02 or chondroitinase ABC produced no 
small unsulphated peaks. These findings suggest the presence of 
HS and CS in a hybrid molecule. Unfortunately no unsulphated 
peak was observed after treatment with both HNOa and chon­
droitinase ABC, but there was loss of radioactivity near the void 
volume. This peak is probably diluted in the large bed volume of
the column.
SDS/PAGE was used to determine the size of the hybrid core 
protein (Figure 5). For this purpose peak II of glomerular 
visceral epithelial cells was treated with chondroitinase ABC,
heparitinase or both. After silver staining, several irrelevant 
protein bands appeared within the heparitinase control. The 
arrow identifies the sharp band observed between 97 and 66 kDa, 
which appeared after both enzyme treatments of peak II (Figure
5, lane 3). This band represents the core protein of the hybrid 
molecule. Note that it is specific, as it is not seen in lanes 5 and
6 in which the enzymes alone were analysed. No such 80 kDa 
band was generated when peak II was treated with either of the 
enzymes alone (lanes 2 and 4). As a control, peak I from 
glomerular-visceral-epithelial-cell culture medium was run both 
before and after heparitinase digestion. HSPG core protein 
migrated with a molecular mass of about 380 kDa (estimated by 
extrapolation; lane 7). To analyse whether the different types of 
glycosaminoglycan were independently attached to the core 
protein or attached via each other, 1.8% polyacrylamide/0.6 % 
agarose-gel electrophoresis was performed. Large quantities of 
peaks I and II of the glomerular-visceral-epithelial-cell culture 
medium were purified (for purity see Figure 5) as described in the 
Materials and methods section. These peaks were labelled with 
125I in the presence of Iodobeads at room temperature for
20 min. The protein-bound iodine was separated from free iodine 
on a Sephadex G-50 column. When 126I-labelled peak II was 
treated with heparitinase, there was a reduction (46.5 %) (Figure
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Figure 4 Analysis of peak II of glomerular-vlsceral-eplthellal-cell culture medium
Peak II of glomerular-visceral-eplthelial-cell culture medium was separated on a Hlload 16/60 Superdex HR200 column without treatment (a) or after treatment with chondroitlnase ABC (b) or 
HN02 (c). Culture media from mesanglal cells containing a mixture of HSPG and CSPG, not treated (d ) or treated with chondroitlnase ABC (e ) or HN02 (f), were used as controls, — , 3H;
35c
r w - %  LJ— 1 J
6, lane 4) in the intensity of the eluted band compared with the 
untreated material (Figure 6, lane 3). When peak II was treated 
with chondroitinase ABC a reduction in intensity (73.7 %) of the 
original band was observed (lane 5). However, the band com­
pletely disappeared only when peak II was treated with both 
enzymes (lane 6). That the hybrid proteoglycan did not show a 
large change in migration in polyacrylamide/agarose after 
chondroitinase ABC treatment has been shown by Klein et al. 
[7]. It can be explained by the fact that only a few CS chains may 
have been present in the molecule (see also Figure 4; sensitivity 
to chondroitinase ABC was 35%). The different glycosamino-
glycan chains probably account for only a small proportion 
of the molecular mass of the intact proteoglycan (compare 
Figure 3a with Figure 3b). A relatively small CS chain may, 
however, account for a substantial proportion of the negative 
change. This may explain the large decrease in intensity on the 
autoradiogram after chondroitinase treatment (Figure 6). This 
confirms that the different glycosaminoglycans (CS and HS) are 
independently attached to one core protein, as disappearance of 
the band would have occurred after only one of the enzyme 
treatments if the different glycosaminoglycans were attached to 
each other.
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Table 3 Production of HS as quantified by ELISA
The cell line is denoted by the age of the donor.
Cell line
Mesangial
48
41
66
Glomerular visceral epithelial
52
25
1.5
HS {/ig/72 h per 106 cells)
36.8 ±10.84 
45.45 ±6 .17  
29.78 ± 8 .0
241.42 ±54.83 
269.40 ±39.83 
197.56 ±17.86
Figure 5 SDS/PAGE of DEAE-Sephacel- and Superdex HR200-purified HS 
and hybrid molecule synthesized by glomerular visceral epithelial cells
HSPG and the hybrid molecule bearing HS and CS were purified as described In the Materials 
and methods section. Equivalent quantities of the purified hybrid proteoglycans were subjected 
to SDS/PAGE (5% gel) under reducing conditions before (lane 1) and after digestion with 
heparitinase (lane 2), chondroitinase ABC (lane 4) or both (lane 3). The arrow Indicates the 
position to which the core protein from the hybrid molecule without HS and CS migrated. HSPG 
isolated from the culture medium of glomerular visceral epithelial cells both before (lane 8) and 
after digestion with heparitinase (lane 7) was run as a control. Lanes 5 and 6 represent analysis 
of chondroitinase ABC and heparitinase respectively. Molecular-mass markers (kDa) are 
indicated on the right.
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Figure 7 Effect of cycloheximide (1 /¿g/ml) on HS production by mesangial 
cells (a and b) and glomerular visceral epithelial cells (c and d) in culture
Heparitinase... -  
Chondroitinase... +
Cells were cultured for 3 days in the presence ( + )  or absence ( — ) of cycloheximide; culture 
media were then collected, and HS was determined by ELISA (a,c). Cells were washed, fresh 
culture medium was added and collected after 3 days and again tested for HS (b,d),
Figure 6 Gel electrophoresis of DEAE-Sephacel- and Superdex HR200- 
purified HS and hybrid molecule synthesized by glomerular visceral epithelial 
cells
HSPG and the hybrid molecule bearing HS and CS were purified as described in the Materials 
and methods section. Equivalents quantities of m l-radlolabelled hybrid proteoglycans were 
subjected to electrophoresis on 1.8% polyacrylamide/0.6 % agarose before (lane 3) and after 
digestion with heparitinase (lane 4), chondroitinase ABC (lane 5) or both (lane 6). As a control, 
125i-labelled HSPG isolated from glomerular visceral epithelial cells both before (lane 1) and after 
(lane 2) digestion with heparitinase were run. The arrow indicates the position to which HS from 
bovine kidney migrated.
Production of HS
Glomerular visceral epithelial cells and mesangial cells were 
cultured in 12-well plates to confluence in medium after which 
they were starved for 24 h in DMEM containing 0.5 % tfFCS. 
The cells were then washed three times with PBS, and fresh 
medium was added to the wells. Three wells were treated with 
trypsin and the cells were counted in a Coulter counter to deter­
mine the number present at the beginning of the assay. After 3 
and 6 days, the culture media (1 ml/well) were harvested and HS 
production was assessed. The results are means ±  S.D. from three 
different cultures. Cell numbers did not change significantly 
during the experiment. Mesangial cells produced between 29.8
and 45.5 /¿g/72 h per 10B cells (Table 3) when cultured for 3 days; 
glomerular visceral epithelial cells produced significantly 
higher levels (between 197.56 and 269.40//g/72 h per 10° cells 
(P <  0.001). Evidence for de novo synthesis of HS was obtained by 
blocking the translation with cycloheximide. Cells were cultured 
for 72 h in the presence or absence of 1 jtcg/ml cycloheximide and 
then culture media were collected and HS was assessed by 
ELISA. Cycloheximide inhibited HS production by mesangial 
cells from 39.1 +  1.16 to 6.98 ±  0.68 /¿g/72 h per 10° cells 
(P <  0.001) and by glomerular visceral epithelial cells from 
241.42 + 54.83 to 66.49 +  17.89/72 h per 106 cells (Figure 7). The 
effects of cycloheximide were completely reversible 72 h after 
treatment, suggesting that the synthesis was de novo and that no 
cytotoxicity had occurred.
Expression of perlecan
Expression o f perlecan in the two types of glomerular cell was 
analysed by the RT-PCR method. Cells were grown in T25 flasks 
in medium for 3 days, and total RNA was isolated. We used a 
gene-specific primer (nested cDNA primer) for cDNA synthesis 
which lies adjacent to, and downstream of, a pair of PCR 
primers used in the second step for PCR amplification. The
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Figure 8 Agarose-gel electrophoresis of RT-PCR fragments
Fragments originating from GAPDH primers (lanes 4 and 5) or periecan primers (lanes 2 and 
3) of glomerular visceral epithelial cells (lanes 2 and 4) or mesangial cells (lanes 3 and 5) are 
shown. Bands were visualized by staining the 1.4% agarose gel with ethidium bromide. In 
lane 1 (AW/fldlll) and lane 6 (100 bp ladder) molecular-mass markers were run.
chondroitinase ABC or H N 02 changed from 0.047 (400 kDa) to 
0.053 (360 kDa) or 0.060 (330 kDa) respectively. When a mixture 
of HS and DS was fractionated on a Superdex HR200 column, 
a separate unsulphated [3H]leucine peak was indeed observed 
(Figures 4e and 4f). If a mixture of CS and HS had been present 
in peak II, a separate unsulphated [3H]leucine peak would have 
been observed as in Figures 4(e) and 4(f). Controls were also 
performed with a mixture of HSPG (isolated from the GBM of 
human kidneys [34]) and CSPG from whole shark cartilage 
(Sigma). The same effects of HNOa and chondroitinase ABC on 
this mixture using Superdex HR200 column fractionation was 
observed (results not shown). It was suggested previously [7] that 
glomerular visceral epithelial cells produce a hybrid molecule; 
however, this was not analysed in detail. This group also
CS/DS
confirmed by
(50.1% sensitive to HNOa, 35.4% sensitive to chondroitinase 
ABC and 34.3 % sensitive to chondroitinase AC). The hybrid 
molecule could be composed of HS and CS chains linked to one 
core protein or CS and HS attached via each other to one core
specificity afforded by this methodology is evident from the protein. The fact that the sum of the HNOa and chondroitinase 
presence of only one detectable PCR product of the expected size ABC sensitivities is less than 100% makes us favour the first 
(269 bp). This method can be used for semiquantitative measure- possibility. To investigate this hypothesis, 1.8% polyacryl-
ment of mRNA [41,42]. Both cell types show amplification of amide/0.6 % agarose-gel electrophoresis was performed, and
domain I of the human perlecan sequence (Figure 8). The from the results it was deduced that HS and CS were in-
GAPDH controls of the two cell types were more or less dependency attached to the core protein of the hybrid molecule,
comparable. The intensity of the perlecan PCR fragment from Rapraeger et al. [43] have previously reported another hybrid
mesangial cells is greater than that from glomerular visceral proteoglycan, syndecan-1, bearing both HS and CS produced by
epithelial cells, suggesting higher steady-state perlecan mRNA mouse mammary epithelial cells and Kato et al. [44] have also
levels in mesangial cells.
DISCUSSION
found a hybrid proteoglycan with the same core protein bearing 
HS and CS side chains. This latter group suggested that the CS 
content of a hybrid proteoglycan may be involved in modifying 
the potential binding activity of HS to other basement-membrane 
The two cell types used in this study were fully characterized on components. This feature may be important, as binding of HS to 
the basis of their morphology and immunofluorescence with other basement-membrane components may be involved in 
different specific antibodies. The results confirm and extend several kidney diseases. The occurrence of a hybrid proteoglycan 
earlier reports [1,30,31]. As the isolated glomerular preparation has also been described in more recent studies. Danielson et al. 
was decapsulated and virtually free of fragments of Bowman’s [45] isolated a hybrid proteoglycan synthesized by EHS-derived 
capsule and tubules when studied by phase-contrast microscopy, cells containing two to three HS chains and one CS chain 
a visceral rather than a parietal origin of the epithelial cells seems attached to a large 400 kDa protein core. Isemura et al. [46] 
likely. Positive staining of the cultured glomerular visceral purified from human placenta a hybrid proteoglycan with a 
epithelial cells with TN10 confirms that these cells were visceral 800 kDa core protein and both HS and DS side chains. It is clear
in origin [32].
/
that the various hybrid proteoglycans described vary in molecular 
size and glycosaminoglycan content. Also differences in the size
labelled macromolecules synthesized by adult mesangial cells of the core protein were found. However, both the results of
and glomerular visceral epithelial cells are proteoglycans, but Klein et al. [7] and our studies suggest the production of a large
they are qualitatively and quantitatively different. Mesangial hybrid proteoglycan containing both HS and CS side chains
cells were found to produce both HSPG and DSPG, which were attached to a small 80 kDa core protein.
isolated from the culture medium and cell layer. Glomerular Up until now all studies on proteoglycan production by
visceral epithelial cells produced HSPG and CSPG (almost glomerular visceral epithelial cells and mesangial cells have been 
equally sensitive to chondroitinase ABC and AC [7]). However, performed by metabolically labelling these cells with Na235S04
and [3H]glucosamine or [3H]leucine. One of the advantages of
3H-
isolation of proteoglycans from the culture medium suggests the 
presence of a hybrid molecule bearing HS and CS (peak II,
Figure 2c), as digestion of this peak demonstrated sensitivity to labelled glycosaminoglycan or 3H-labelled core protein can be
this method is that the ratio between Na235S04 and
studied in detail. Furthermore, this method allows the possibility 
of studying all types of proteoglycan produced by these cells, and 
determination of their molecular masses. However, quantification 
of metabolic labelling can lead to serious errors if it is the sole 
method used. As far as we know, it has not been possible to 
column. This resulted in a single peak (Kav 0.047). Treatment determine accurately the amount of HSPG produced. Using
HNOa (50.1 %), chondroitinase ABC (35.4 %) and chondroitinase 
AC (34.3 %) (Figure 3 and Table 2). For more detailed analysis, 
metabolic labelling with Na235S04 and [3H]leucine was per­
formed. The isolated peak II was fractionated using molecular- 
sieve chromatography on a Hiload 16/60
newly developed antibodies specific for GBM HS side chains in 
a sensitive inhibition ELISA, the production of HSPG by both
with either chondroitinase ABC or HNOa resulted in no large 
shift in a part of the 3H-labelled peak, suggesting that only one 
core protein was present (Figure 4). A shift should have been glomerular visceral epithelial cells and mesangial cells can be 
observed as the expected molecular mass of the hybrid core measured more accurately. This will enable the study of factors 
protein is only 80 kDa [7]. The Kav of the fraction treated with that affect HSPG production. Results of such studies can then be
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of Naa35SO,/[3H]glucosamine orcompared with those 
[3H]leucine incorporation into macromolecules. This might allow 
differentiation between release of stored HSPG and de novo 
production and also comparison between the production of 
perlecan and non-perlecan HSPG. Recent studies performed in 
our laboratory show high reactivity of the mAbs used in this 
ELISA against the large basement-membrane HSPG (perlecan) 
(results not shown). RT-PCR demonstrates expression of 
perlecan in both cell types. As the method used theoretically 
cannot precisely reflect the steady-state level of perlecan mRNA, 
Northern-blot analysis was performed and revealed that glom­
erular visceral epithelial cells express mRNA at a lower level than 
mesangial cells (results not shown).
In summary, this study describes the production of DSPG and 
HSPG as well as expression of perlecan mRNA in mesangial 
cells. Glomerular visceral epithelial cells produce CSPG and 
HSPG and a hybrid molecule bearing HS and CS chains 
independently attached to its core protein. These cells also 
express perlecan. The majority of HSPG produced by the two 
cell types reacts with mAbs known to bind to perlecan, whereas 
the hybrid does not. Glomerular visceral epithelial cells produced 
significantly higher amounts of HS than do mesangial cells as 
revealed by the HS-specific ELISA.
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